• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2001 Fiscal Year Final Research Report Summary

Aberrant intracellular signaling in the pathogenesis of muscular dystrophy

Research Project

Project/Area Number 11470152
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field Neurology
Research InstitutionKAWASAKI MEDICAL SCHOOL

Principal Investigator

SUNADA Yoshihide  Kawasaki Medical School, Neurology, MD, 医学部, 教授 (00240713)

Co-Investigator(Kenkyū-buntansha) OHI Hiroaki  Showa University, Pharmaceutical Science, PhD, 薬学部, 講師 (60194065)
OHSAWA Yutaka  Kawasaki Medical School, Neurology, Professor, 医学部, 講師 (80246511)
MURAKAMI Tatsufumi  Kawasaki Medical School, Neurology, Professor, 医学部, 助教授 (30330591)
MATSUMURA Kiichiro  Teikyo University, Neurology, Professor, 医学部, 助教授 (50260922)
ARATA Satoru  Showa University, Biotechnology, PhD, 薬学部, 講師 (20159502)
Project Period (FY) 1999 – 2001
Keywordsmuscular dystrophy / signal transduction / transgenic mouse / model animal / caveolin
Research Abstract

Caveolin is the principal component of caveolae microdomain in the plasma membrane and plays importantroles in modulating signal transduction. Recent studies demonstrated that mutations in the caveolin-3 gene, the muscle-specific caveolin isoform, cause several types of myopathy including limb-girdle muscular dystrophy (LGMD 1C). To understand the molecular mechanisms underlying muscle degeneration in caveolin-3 deficiency, we have been working on generation and characterization of the mutant (P104L) caveolin-3 transgenic (Tg) mice. Tg mice developed myopathic symptoms and skeletal muscle pathology showed myopathic changes with decreased density of caveolae in the plasma membrane. Surprisingly numerous rimmed vacuoles were observed. Overexpression of the mutant caveolin-3 mRNA resulted in deficiency of the caveolin-3 protein, which implicates a dominant negative effect of the mutation. We demonstrated a significant increase of nNOS activity fhat may be involved in the pathogenesis. Gene expression profile analysis using DNA array technology revealed eight up-regulated genes including c-Jun, ubiquitin conjugate E2p, G-protein-coupled receptor 25, laminin (32, defender against apoptotic cell death (dad-1), etc. and four down-regulated genes including glucocorticoid receptor form A and TNF receptor 1.More interestingly, one of the up-regulated genes, dad-1 has the anti-apoptotic activity against apoptosis related to ER stress. These results suggest that caveolin-3 deficiency caused by a dominant negative effect leads to alteration in apoptotic signaling pathways and results in muscle degeneration.

  • Research Products

    (16 results)

All Other

All Publications (16 results)

  • [Publications] Saito, T.et al.: "Characterization of the transmembrane molecular architecture of the dystroglycan complex in Schwann cells"J.Biol.Chem.. 274. 8240-8246 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Matsumura, K.et al.: "Sarcoglycan complex : a muscular supporter of dystroglycan-dystrophin interplay?"Cell.Mol.Biol.. 45. 751-762 (1999)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Masaki, T.et al.: "Expression of dystroglycan and laminin-2 in peripheral nerve under axonal degeneration and regeneration"Acta Neuropathol.. 99. 289-295 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Sunada, Y.et al.: "Transgenic mice expressing mutant caveolin-3 show severe myopathy associated with increased nNOS activity"Hum.Mol.Genet.. 10. 173-178 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Sunada, Y.et al.: "Caveolin-3 and muscular dystrophy"Acta Myologica. 20. 162-167 (2001)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Sunada, Y.et al.: "Deficiency of a 180-kDa extracellular matrix protein in Fukuyama type congenital muscular dystrophy skeletal muscle"Neuromusc.Disord.. 12. 117-120 (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Sunada, Y.: "Neurogenetics (The muscular dystrophies)"Ed.Pulst S., Oxford University Press. 458 (2000)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] 砂田芳秀: "医学のあゆみ(Caveolin欠損)"医歯薬出版(印刷中). (2002)

    • Description
      「研究成果報告書概要(和文)」より
  • [Publications] Saito, T.et al: "Characterization of the transmembrane molecular architecture of the dystroglycan complex in Schwann cells."J. Biol. Chem.. 274. 8240-8246 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Matsumura, K.et al: "Sarcoglycan complex : a muscular supporter of dystroglycan-dystrophin interplay?"Cell. Mol. Biol. 45. 751-752 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Masaki, T.et ah: "Expression of dystroglycan and laminin-2 in peripheral nerve under axonal degeneration and regeneration."Acta Neuropathol. 99. 289-295 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Sunada, Y.et al: "Transgenic mice expressing mutant caveolin-3 show severe myopathy associated with increased nNOS activity."Hum. Mol. Genet.. 10. 173-178 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Sunada, Y.et al: "Caveolin-3 and muscular dystrophy"Acta Myologica. 20. 162-167 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Sunada, Y.et al: "Deficiency of a 180-kDa extracellular matrix protein in Fukuyama type congenital muscular dystrophy skeletal muscle"Neuromusc. Disord.. 12. 117-120 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Sunada, Y.et al: "Ed.Pulst S., Oxford University Press, New York,"Neurogenetics In The muscular dystrophies. 77-103 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
  • [Publications] Sunada, Y et al: "Neurogenetics In The muscular dystrophies"Ed. Pulst S., Oxford University Press, New York. 77-103 (2000)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2003-09-17  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi